Urgent.News

What's breaking now, across thousands of outlets.

Business

After Wegovy and Zepbound, 6 weight-loss drugs in development

New weight-loss drugs from Novo Nordisk, Eli Lilly, Pfizer, Roche, Amgen and Viking Therapeutics offer a look at where obesity treatment could go after Wegovy and Zepbound

After Wegovy and Zepbound, 6 weight-loss drugs in development

We haven't written up this one. Quartz has the full story — the link below goes straight to it.

Read the original at qz.com →

More in Business

More from Wednesday 28 October →